Today’s article highlights three generic drug stocks that you may want to check out. Here’s what they had to say about one of them, “If you’re looking for impressive numbers in a generic drug stock, look no further than Lannett. The company made nearly $274 million in revenue with over $57 million going to the bottom line last fiscal year. Lannett’s return on equity stands at 40% — a figure that would bring smiles to the faces of most investors.” To read more, CLICK HERE.
